UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression

Pain

Volumn 75, Issue 2-3, 1998, Pages 281-293

  Honoré, Prisca ^a   Buritova, Jaroslava ^a   Chapman, Victoria ^a   Besson, Jean Marie ^a  

^a PSL RESEARCH UNIVERSITY   (France)

Author keywords

A1 receptor antagonist (DPCPX); A2 receptor antagonist (DMPX); Adenosine analogue; c Fos protein expression; Carrageenan inflammation; Dorsal horn; Nociception; UP 202 56

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR BLOCKING AGENT; CARRAGEENAN; PROTEIN C FOS; UNCLASSIFIED DRUG; UP 20256;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EDEMA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN;

ADENOSINE; ADMINISTRATION, ORAL; ANIMALS; CARRAGEENAN; EDEMA; HINDLIMB; INDOLES; MALE; PROTO-ONCOGENE PROTEINS C-FOS; PURINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; SPINAL CORD; THEOBROMINE; XANTHINES;

EID: 0031924143     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00006-2     Document Type: Article

References (76)

1. Abbadie, C., Honoré, P. and Besson, J.-M., Postsynaptic changes during sustained primary afferent fiber stimulation as revealed by c-Fos immunohistochemistry in the rat spinal cord. In: L. Urban, A. Dray, S. Jeftinija, P. Reeh and C.J. Woolf (Eds.), The Cellular Mechanisms of Sensory Processing, Laszlo Urban, Berlin, 1994, pp. 449-471.
2. 6-(R-phenyllisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence in mice. Eur. J. Pharmacol. 112:1985;171-179.
3. Aran S., Proudfit H.K. Antinociception produced by interactions between intrathecally administered adenosine agonist and norepinephrine. Brain Res. 513:1990;255-263.
4. Besson, J.-M., Honoré, P., Chapman, V., Buritova, J., Camborde, F., Güngör, T., Caussade, F., Teulon J.-M. and Cloarec, A., The antinociceptive effects of UP 202-56, an adenosine agonist, on various nociceptive tests and carrageenin induced spinal c-Fos expression in rodents. In: Abstracts of the 8th World Congress on Pain, IASP Press, Seattle, WA, 1996, p. 127 (Abstract 57).
5. Braas K.M., Newby A.C., Wilson V.S., Snyder S.H. Adenosine-containing neurons in the brain localized by immunochemistry. J. Neurosci. 6:1986;1952-1961.
6. 1 receptors mediate inhibition of tachykinin release from perifused enteric nerve endings. Am. J. Physiol. 262:1992;G525-G531.
7. 1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropyl xanthine to rat brain membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 335:1987;59-63.
8. Buritova, J., Honoré, P., Chapman, V. and Besson, J.-M., Concurrent reduction of inflammation and spinal Fos-LI neurons by systemic diclofenac, Neurosci. Lett., 188 (1995a) 175-178.
9. Buritova, J., Honoré, P., Chapman, V. and Besson, J.-M., Carrageenan oedema and spinal Fos-LI neurons are reduced by piroxicam in the rat, NeuroReport, 6 (1995b) 1385-1388.
10. Buritova, J., Chapman, V., Honoré, P. and Besson, J.-M., Interactions between NMDA and prostaglandin receptor mediated events in model of inflammatory nociception, Eur. J. Pharmacol., 303 (1996a) 91-100.
11. Buritova, J., Honoré, P. and Besson, J.-M., Ketoprofen produces profound inhibition of spinal c-Fos protein expression resulting from an inflammatory stimulus but not from noxious heat, Pain, 67 (1996b) 379-389.
12. Buritova, J., Honoré, P., Chapman, V. and Besson, J.M., Enhanced effects of co-administered dexamethasone and diclofenac on inflammatory pain processing and spinal c-Fos expression in the rat: synergistic mechanisms, Pain, 64 (1996c) 559-568.
13. Buritova J., Besson J.-M. Dose-related anti-inflammatory/analgesic effects of lornoxicam: a spinal c-Fos protein study in the rat. Inflamm. Res. 47:1998;18-25.
14. Camborde, F., Hertz, F., Virone-Oddos, A., Caussade, F., Güngör, T. and Cloarec, A., Assessment of the antinociceptive effects of UP 202-32, an adenosine analogue, in various models of pain. In: Abstracts of the 7th World Congress on Pain, IASP Publications, Seattle, WA, 1993, p. 518 (Abstract 1370).
15. Camborde, F., Virone-Oddos, A., Caussade, F., Güngör, T., Teulon, J.M., Hertz, F. and Cloarec, A., Potent analgesic effects of adenosine analogues in models of nociceptive and neuropathic chronic pain. In: Abstracts of the 12th International Congress of Pharmacology, Canadian Journal of Physiology and Pharmacology, 72 (Suppl. 1), 1994, p. 344 (Abstract P13.4.13).
16. Chapman V., Honoré P., Buritova J., Besson J.M. Cholecystokinin B receptor antagonism enhances the ability for a low dose of morphine to reduce c-Fos expression int eh spinal cord of the rat. Neuroscience. 67:1995;731-739.
17. Choca J.I., Green R.D., Proudfit H.K. Adenosine A1 and A2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study. J. Pharmacol. Exp. Ther. 247:1988;757-764.
18. Choca J.I., Proudfit H.K., Green R.D. Identification of A1 and A2 adenosine receptors in the rat spinal cord. J. Pharmacol. Exp. Ther. 242:1987;905-910.
19. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76:1994;5-13.
20. 2 adenosine receptors in spinal mechanisms of antinociception. Eur. J. Pharmacol. 139:1987;215-223.
21. Delander G.E., Wahl J.J. Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally. J. Pharmacol. Exp. Ther. 246:1988;565-570.
22. Doak G.J., Sawynok J. Complex role of peripheral adenosine in the genesis of the response to subcutaneous formalin in the rat. Eur. J. Pharmacol. 281:1995;311-318.
23. Doi T., Kuzuna S., Maki Y. Spinal antinociceptive effects of adenosine compounds in mice. Eur. J. Pharmacol. 137:1987;227-231.
24. Dolphin A.C., Forda S.R., Scott R.H. Calcium-dependent currents in cultured rat dorsal root ganglion neurones are inhibited by an adenosine analogue. J. Physiol. 373:1986;47-61.
25. Draisci G., Iadarola M.J. Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol. Brain Res. 6:1989;31-37.
26. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
27. Geiger J.D., Labella F.S., Nagy J.I. Characterization and localization of adenosine receptors in rat spinal cord. J. Neurosci. 4:1984;2303-2310.
28. 3H]cyclohexyladenosine. J. Neurosci. 2:1982;1230-1241.
29. 6-substituted adenosine receptor agonists. Synthesis and pharmacological activity as potent antinociceptive agents. J. Med. Chem. 37:1994;4307-4316.
30. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
31. Herrick-Davis K., Chippari S., Luttinger D., Ward S.J. Evaluation of adenosine agonists as potential analgesics. Eur. J. Pharmacol. 162:1989;365-369.
32. Holmgren M., Hedner J., Mellstrand T., Nordgerg G., Hedner T.H. Characterization of the antinociceptive effects of some adenosine analogues in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 334:1986;290-293.
33. 6-phenylisopropyladenosine. J. Pharm. Pharmacol. 35:1983;679-680.
34. Honoré, P., Buritova, J. and Besson, J.M., Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin, Eur. J. Pharmacol., 272 (1995a) 249-259.
35. Honoré, P., Buritova, J. and Besson, J.M., Aspirin and paracetamol reduced both Fos expression in rat lumbar spinal cord and inflammatory signs produced by carrageenin inflammation, Pain, 63 (1995b) 365-375.
36. Honoré, P., Chapman, V., Buritova, J. and Besson, J.-M., Concomitant administration of morphine and an NMDA receptor antagonist profoundly reduced inflammatory evoked spinal c-Fos expression, Anesthesiology, 85 (1996a) 150-160.
37. 2-adrenoceptor and μ opioid agonists influence noxiously evoked c-Fos expression in the rat? A pharmacological study, J. Pharmacol. Exp. Ther., 278 (1996b) 393-403.
38. Hsu S., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
39. Hughes P., Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated expression within the nervous system. Pharmacol. Rev. 47(1):1995;133-178.
40. Iadarola M.J., Brady L.S., Draisci G., Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain. 35:1988;313-326.
41. Joris J., Costello A., Dubner R., Hargreaves K. Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain. 43:1990;95-103.
42. Karlsten R., Gordh T., Hartving P., Post C. Effects of intrathecal injection of the adenosine receptor agonist R-phenylisopropyl-adenosine and N-ethylcarboxamide-adenosine on nociception and motor function in the rat. Anesth. Analg. 71:1990;60-64.
43. Karlsten R., Gordh T., Post C. Local antinociceptive and hyperalgesic effects in the formalin test after peripheral administration of adenosine analogues in mice. Pharmacol. Toxicol. 70:1992;434-438.
44. 1-adenosine receptor. Neurosci. Lett. 121:1991;267-270.
45. Kayser V., Guilbaud G. Local and remote modifications of nociceptive sensitivity during carrageenin-induced inflammation in the rat. Pain. 28:1987;99-107.
46. Keil G.J., Delander G.E. Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice. Eur. J. Pharmacol. 271:1994;37-46.
47. Lesch M.E., Ferin M.A., Wright C.D., Schrier D.J. The effects of (R)-N-(1-methyl-2-phenylethyl) adenosine (L-PIA), a standard A1-selective adenosine agonist, on rat acute models of inflammation and neutrophil function. Agents Actions. 34:1991;25-27.
48. Li J., Perl E.R. Adenosine inhibition of synaptic transmission in the substantia gelatinosa. J. Neurophysiol. 72:1994;1611-1621.
49. Malmberg A.B., Yaksh T.L. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and isobolographic analysis of the NSAID interaction. Anesthesiology. 79:1993;270-281.
50. Molander C., Xu Q., Grant G. The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. J. Comp. Neurol. 230:1984;133-141.
51. Morgan, J.I., Discussions in Neuroscience, Proto-oncongene Expression in the Nervous System, Elsevier, Amsterdam, 1991.
52. Morgan J.I., Curran T. Immediate-early genes: ten years on. Trends Neurosci. 18:1995;66-67.
53. Munglani R., Hunt S.P. Molecular biology of pain. Br. J. Anaesthesia. 75:1995;186-192.
54. Nagy J.I., Daddona P.E. Anatomical and cytochemical relationships of adenosine deaminase-containing primary afferent neurons in the rat. Neuroscience. 15:1985;799-813.
55. Newson, G.C., Pirec, V. and Proudfit, H.K., Different adenosine receptors in the spinal cord modulate the nociceptive responses to high and low skin heating rates. In: 25th Annual Meeting of Society for Neuroscience, in San Diego, CA, Soc. Neurosci. Abstr., Vol. 21, Part1, 1995, p. 384 (Abstract 158.8).
56. Noguchi K., Kowalski K., Traub R., Solodkin A., Iadarola M.J., Ruda M.A. Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Mol. Brain Res. 10:1991;227-233.
57. Noguchi K., Dubner R., Ruda M.A. Preproenkephalin mRNA in spinal dorsal horn neurons is induced by peripheral inflammation and is co-localized with Fos and Fos-related proteins. Neuroscience. 46:1992;561-570.
58. Poon A., Sawynok J. Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration. Eur. J. Pharmacol. 286:1995;177-184.
59. Post C. Antinociceptive effects in mice after intrathecal injection of 5′-N-ethylcarboxamide adenosine. Neurosci. Lett. 51:1984;325-330.
60. Reeve A.J., Dickenson A.H. The role of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat. Br. J. Pharmacol. 116:1995;2221-2228.
61. Reeve A.J., Dickenson A.H. Electrophysiological study on spinal antinociceptive interactions between adenosine and morphine in the dorsal horn of the rat. Neurosci. Lett. 194:1995;81-84.
62. Santicioli P., Delbianco E., Maggi C.A. Adenosine A1 receptors mediate the presynaptic inhibition of calcitonin gene-related peptide release by adenosine in the rat spinal cord. Eur. J. Pharmacol. 231:1993;139-142.
63. Sawynok, J., Purines and nociception. In: K.A. Jacobsen and M.F. Jarvis (Eds.), Purinergic Approaches in Experimental Therapeutics, Wiley Liss, New York, 1997, pp. 495-513.
64. Sawynok J., Sweeney M.I. The role of purines in nociception. Neuroscience. 32:1989;557-569.
65. Sawynok J., Sweeney M.I., White T.D. Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br. J. Pharmacol. 88:1986;923-930.
66. Schrier D.J., Lesch M.E., Wright C.D., Gilbersten R.B. The antiinflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflammatory response in rats. J. Immunol. 145:1990;1874-1879.
67. Seale T.W., Abla K.A., Shamin M.T., Carney J.M., Daly J.M. 3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. Life Sci. 43:1988;1671.
68. 2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord. J. Pharmacol. Exp. Ther. 250:1989;915-922.
69. Sosnowski M., Yaksh T.L. Role of spinal adenosine receptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism. Anesth. Analg. 69:1989;587-592.
70. + release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord. J. Pharmacol. Exp. Ther. 248:1989;447-454.
71. Taiwo Y.O., Levine J.D. Direct cutaneous hyperalgesia induced by adenosine. Neuroscience. 38:1990;757-762.
72. Tamura, H., Ishikawa, T., Ujihara, H., Kakumoto, S. and Sakabe, T., Role of spinal adenosine receptors in modulating formalin-induced tissue injury. In: 25th Annual Meeting of Society for Neuroscience in San Diego, CA, Soc. Neurosci. Abstr., Vol. 21, Part 1, 1995, p. 651 (Abstract 263.11).
73. Vapaatalo H., Onken D., Neuvonen P.J., Westermann E. Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA). Drug Res. 25:1975;407-410.
74. Winter C.A., Risley E.A., Nuss G.W. Carrageenan-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol. Med. 111:1962;544-547.
75. Zieglgansberger W., Tölle T.R. The pharmacology of pain signalling. Curr. Opin. Neurobiol. 3:1993;611-618.
76. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.